TrialBMC ophthalmology2023

Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial.

A Tarakeswara Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.